Next Article in Journal
Formulating Resveratrol and Melatonin Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) for Ocular Administration Using Design of Experiments
Previous Article in Journal
Biomolecules to Biomarkers? U87MG Marker Evaluation on the Path towards Glioblastoma Multiforme Pathogenesis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Yadav et al. PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression. Pharmaceutics 2022, 14, 1326

1
College of Pharmacy, Gachon University, #191, Hambakmoeiro, Yeonsu-gu, Incheon 21936, Republic of Korea
2
Molecular and Human Genetics Lab, Department of Zoology, University of Lucknow, Lucknow 226007, India
3
Electrophysiology Lab, School of Biomedical Engineering, Banaras Hindu University, Varanasi 221005, India
*
Authors to whom correspondence should be addressed.
Pharmaceutics 2024, 16(1), 124; https://doi.org/10.3390/pharmaceutics16010124
Submission received: 12 December 2023 / Accepted: 25 December 2023 / Published: 18 January 2024

Additional Affiliation

In the published publication [1], there was an error regarding the affiliation for Neera Yadav. In addition to affiliation 1, the updated affiliation should include: Molecular and Human Genetics Lab, Department of Zoology, University of Lucknow, Lucknow 226007, India. Neera Yadav did not act as the corresponding author any more.

Addition of Two Authors

Shama Parveen and Monisha Banerjee (the corresponding author) were not included as authors in the original publication [1]. The corrected Author Contributions statement appears here. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Shama Parveen: investigation, formal analysis, methodology;
Monisha Banerjee: project administration, funding acquisition, resources, supervision, writing—review and editing.

Addition of Acknowledgement

The authors also acknowledge Ratan Singh Ray, CSIR-Indian Institute of Toxicology Research (IITR), Lucknow, India, for the synthesis of nanoparticles; Birbal Sahni Institute of Palaeosciences (BSIP), Lucknow, for the SEM facility; Centre of Excellence, Higher Education Government of Uttar Pradesh for the cell culture facility at the Molecular and Human Genetics Laboratory, Department of Zoology, University of Lucknow, Lucknow-226007, India.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor and Editor-in-Chief. The original publication has also been updated.

Reference

  1. Yadav, N.; Tripathi, A.K.; Parveen, A.; Parveen, S.; Banerjee, M. PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression. Pharmaceutics 2022, 14, 1326. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Yadav, N.; Tripathi, A.K.; Parveen, A.; Parveen, S.; Banerjee, M. Correction: Yadav et al. PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression. Pharmaceutics 2022, 14, 1326. Pharmaceutics 2024, 16, 124. https://doi.org/10.3390/pharmaceutics16010124

AMA Style

Yadav N, Tripathi AK, Parveen A, Parveen S, Banerjee M. Correction: Yadav et al. PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression. Pharmaceutics 2022, 14, 1326. Pharmaceutics. 2024; 16(1):124. https://doi.org/10.3390/pharmaceutics16010124

Chicago/Turabian Style

Yadav, Neera, Amit Kumar Tripathi, Amna Parveen, Shama Parveen, and Monisha Banerjee. 2024. "Correction: Yadav et al. PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression. Pharmaceutics 2022, 14, 1326" Pharmaceutics 16, no. 1: 124. https://doi.org/10.3390/pharmaceutics16010124

APA Style

Yadav, N., Tripathi, A. K., Parveen, A., Parveen, S., & Banerjee, M. (2024). Correction: Yadav et al. PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression. Pharmaceutics 2022, 14, 1326. Pharmaceutics, 16(1), 124. https://doi.org/10.3390/pharmaceutics16010124

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop